Search

Search Results

• NK-Cell Receptor Repertoire in Chronic Myeloid Leukemia

  Tamara Vangelevna Chitanava, R.A. Vlasik, L.O. Khordzhasov, A. Ataman, N.S. Luchkina, A.Yu. Aronov, I.D. Matvienko, N.T. Siordiya, O.V. Kulemina, N.S. Lazorko, E.I. Sbityakova, N.A. Shnalieva, E.N. Tochenaya, J.A. Alekseeva, P.A. Butylin, S.V. Smirnov, Yu. A. Zaritskii, Yu.P. Martinova, E.G. Lomaia

  152-161

  01.04.2026

• Treatment Efficacy for Pediatric Acute Myeloid Leukemias: Results of a Single-Center Trial

  E.V. Inyushkina, Sergei Olegovich Gunyakov, A.V. Bogucharskii, V.O. Stepanova

  142-151

  01.04.2026

• Primary Central Nervous System Lymphoma: A Literature Review, Diagnosis, Treatment, and Prognosis

  Selmi Faikovna Ramazanova, A.V. Arakelyan, A.A. Semenova, O.Yu. Baranova, D.N. Tupitsyna, M.Yu. Kichigina, O.P. Trofimova, G.D. Petrova, A.S. Subbotin, V.O. Shpirko, U.G. Koshkina, N.O. Zemlyakov, K.R. Gadzhibekov, G.S. Tumyan

  191-203

  01.04.2026

• The Optimal Background Cut-Off Threshold for Calculating Volumetric PET Biomarkers as Prognostic Factors in Classical Hodgkin Lymphoma

  Mariya Vasilevna Metelkina, I.P. Aslanidi, O.V. Mukhortova, D.M. Pursanova, V.A. Manukova, I.V. Shurupova, T.A. Trifonova, D.D. Zubkov, A.S. Rumyantsev

  39-48

  01.01.2026

• The Prognostic Value of Positron Emission Tomography Findings in the Treatment of Primary Mediastinal (Thymic) Large B-Cell Lymphoma

  A.S. Subbotin, Arman Vachakanovich Arakelyan, G.S. Tumyan, V.V. Solomyanyi, B.M. Khakulova, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, O.P. Trofimova, M.A. Senchenko, V.Yu. Kirsanov

  326-339

  01.10.2025

• DNA Methylation Genes in Multiple Myeloma: What We Already Know and How It Can Be Used?

  Daria Aleksandrovna Chebykina, E.V. Motyko, A.N. Kirienko, D.V. Kustova, O.B. Krysiuk, S.V. Sidorkevich, I.S. Martynkevich

  315-325

  01.10.2025

• Determination of the Minimal Residual Disease Threshold in Acute Myeloid Leukemia Treated with ‘ОМЛ-17’ and ‘mОМЛ-17’ Regimens

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, K.A. Nikiforova, Yu.O. Davydova, N.M. Kapranov, I.A. Lukianova, A.A. Ievleva, Yu.A. Chabaeva, Z.T. Fidarova, L. A. Kuzmina, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  340-346

  01.10.2025

• The Prognostic Value of ТР53 Gene Mutations in Patients with Cutaneous T-Cell Lymphomas

  Liliya Gamilevna Gorenkova, B.V. Biderman, A.K. Smolianinova, E.E. Zvonkov

  227-232

  01.07.2025

• The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  233-241

  01.07.2025

• Comparative Efficacy Analysis of Mobilization and Collection of Autologous Hematopoietic Stem Cells in Patients with Lymphoproliferative Disorders and Multiple Sclerosis

  Oksana Vladimirovna Fedyk, V.O. Sarzhevskii, D.A. Fedorenko, V.Ya. Mel’nichenko, Yu.N. Dubinina, N.E. Mochkin, E.G. Smirnova, D.S. Kolesnikova, A.E. Bannikova

  51-58

  01.07.2025

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• The Prognostic Value of the Galectin-1 Expression by Tumor Plasma Cells and the Concentration of Some Serum Cytokines (IL-2, IL-6, TNF) in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

  Zhanna Mikhailovna Kozich, V.N. Martinkov, D.A. Zinovkin, Zh.N. Pugacheva, N.N. Klimkovich

  65-72

  01.01.2025

• The Role of Somatic Mutations in Various Genes and the Issue of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A Literature Review

  Elena Andreevna Kuzmina, E.Yu. Chelysheva, B.V. Biderman, A.G. Turkina

  10-20

  01.01.2025

• Chronic Lymphocytic Leukemia: A Genomic Landscape and Cellular Signal Pathways

  M.A. Mikhaleva, Evgenii Olegovich Kunevich, A.Yu. Kuvshinov, S.V. Voloshin

  21-37

  01.01.2025

• Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial

  Yana Konstantinovna Mangasarova, R.R. Abdurashidova, A.U. Magomedova, O.V. Margolin, E.S. Nesterova, L.G. Gorenkova, M.O. Bagova, E.A. Fastova, D.S. Belkina, A.M. Kovrigina, N.G. Gabeeva, D.A. Koroleva, S.K. Kravchenko, Yu.A. Chabaeva, E.E. Zvonkov

  335-346

  01.10.2024

• Bone Marrow Lymphocyte Subpopulation in Chronic Lymphocytic Leukemia Patients with Different Responses to Chemotherapy

  Olesya Nikolaevna Selyutina, E.Yu. Zlatnik, N.K. Guskova, I.A. Novikova, I.B. Lysenko, A.B. Sagakyants, T.F. Pushkareva, L.Yu. Vladimirova

  376-383

  01.10.2024

• The Prognostic Value of Cytotoxic CD8-Positive Т-Lymphocytes of the Reactive Tumor Microenvironment in Diffuse Large B-Cell Lymphoma

  Elena Viktorovna Vaneeva, V.A. Rosin, D.A. Dyakonov, N.V. Glubokovskikh

  266-272

  01.07.2024

• KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

  Anna Mikhailovna Sergeeva, V.L. Surin, Yu.A. Chabaeva, A.A. Kraizman, M.V. Solovev, S.M. Kulikov, L.P. Mendeleeva

  256-265

  01.07.2024

• Treatment of Patients with Local Stages of Newly Diagnosed Classical Hodgkin Lymphoma: A Literature Review, Current Approaches, and Our Own Experience

  Evgeniya Viktorovna Paramonova, Yu.I. Klyuchagina, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.V. Arakelyan, A.A. Semenova, E.A. Demina, O.P. Trofimova, A.S. Subbotin, M.A. Senchenko, G.S. Tumyan

  27-36

  17.05.2024

• The Value of Combined PET/CT in Diffuse Large B-Cell Lymphoma: Historical Background, Evolution of Views, and Current Opportunities of the Method (Literature Review)

  Artem Andreevich Vovchenko, N.A. Falaleeva, A.A. Danilenko, A.Yu. Terekhova, M.M. Khodzhibekova, A.M. Chelmakov, A.G. Zamotina, A.S. Dikova, S.V. Ruchkova, Yu.V. Sinitsyna, V.Yu. Kovalskaya, A.N. Perepelitsyna, A.N. Balashova, D.A. Manaenkov, S.A. Ivanov

  66-75

  17.05.2024

• CD20-Positive B-Lymphocytes in the Reactive Tumor Microenvironment as an Independent Immunohistochemical Prognostic Factor in Nodular Sclerosis Classical Hodgkin Lymphoma

  Maksim Sergeevich Minaev

  166-172

  01.04.2024

• PET/CT in Hematological Malignancies: What Has Been Achieved and What Remains to Be Done

  Aleksei Sergeevich Subbotin, A.I. Pronin, T.M. Geliashvili, P.E. Tulin, T.S. Basova, B.M. Khakulova, G.S. Tumyan, A.A. Semenova

  109-128

  01.04.2024

• Primary Immune Thrombocytopenia and Thrombopoietin Receptor Agonists: Feasibilities of Treatment Discontinuation upon Achieving Stable Complete Platelet Response

  O.Yu. Vinogradova, M.M. Pankrashkina, Anna Leonidovna Neverova, M.V. Chernikov, L.A. Mukha, D.I. Shikhbabaeva, V.V. Ptushkin

  413-425

  28.09.2023

• Follicular Lymphoma of Grades 1–3А With and Without t(14;18)(q32;q21): A Prognosis, Choice of Chemotherapy and Its Outcomes

  Ekaterina Sergeevna Nesterova, E.E. Zvonkov, A.M. Kovrigina, T.N. Obukhova, B.V. Biderman, A.B. Sudarikov, Ya.K. Mangasarova, A.U. Magomedova, A.K. Smolyaninova, S.M. Kulikov, E.N. Parovichnikova

  361-369

  28.09.2023

• Mutation Profile of Normal and Tumor Cells in a Patient with Multiple Myeloma: A Case Report

  A.S. Zhuk, I.I. Kostroma, Elena Igorevna Stepchenkova, D.V. Kachkin, O.B. Belopolskaya, I.V. Zotova, A.D. Garifullin, S.V. Voloshin, S.V. Gritsaev, A.Yu. Aksenova

  337-349

  09.06.2023

• Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response

  Natella Iosifovna Enukashvili, L.A. Belik, I.I. Kostroma, N.Yu. Semenova, V.A. Balashova, D.V. Baram, S.V. Gritsaev, S.S. Bessmeltsev, S.V. Sidorkevich, I.S. Martynkevich

  294-302

  09.06.2023

• Classical Hodgkin Lymphoma: Tumor Structure and Prognostic Value of the Immune Microenvironment

  Artem Aleksandrovich Gusak, K.V. Lepik, L.V. Fedorova, V.V. Markelov, V.V. Baykov

  242-262

  09.06.2023

• The Prognostic Value of Somatic Mutations of Epigenetic Regulation Genes in Acute Myeloid Leukemias in Real-World Clinical Practice: Results of an Observational Non-Interventional Prospective Interregional Study

  Aleksina Alekseevna Shatilova, I.G. Budaeva, A.V. Petukhov, S.A. Silonov, A.E. Ershova, T.S. Nikulina, Yu.D. Matvienko, Yu.V. Mirolyubova, K.V. Bogdanov, L.V. Anchukova, Yu.S. Neredko, S.Yu. Tyasko, O.E. Ochirova, A.G. Karpova, E.R. Vasil’eva, O.D. Serdyuk, D.A. Yaskulskii, D.V. Bukin, Yu.A. Alekseeva, E.G. Lomaia, L.L. Girshova

  174-185

  03.03.2023

• The Prognostic Role of Genetic Aberrations in Mantle Cell Lymphoma: A Literature Review and Clinical Experience

  Elizaveta Vyacheslavovna Kleina, S.V. Voloshin, Yu.S. Vokueva, O.D. Petukhova, E.V. Motyko, M.P. Bakai, D.V. Kustova, A.N. Kirienko, S.Yu. Linnikov, E.V. Karyagina, O.S. Uspenskaya, I.S. Zyuzgin, S.V. Sidorkevich, I.S. Martynkevich

  213-226

  03.03.2023

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Approaches to the Treatment of Patients with Myelofibrosis and Polycythemia Vera with Constitutional Symptoms in Real-World Clinical Practice in the Russian Federation: Intermediate Results of a Multi-Center Observational Prospective Clinical Study

  Anait Levonovna Melikyan, I.N. Subortseva, S.M. Kulikov, Yu.A. Chabaeva, E.A. Gilyazitdinova, K.P. Novoselov, E.A. Knyazeva, A.S. Egorova, I.S. Stepochkin, E.V. Koroleva, T.M. Sycheva, V.P. Belgesova, A.Yu. Putintseva, O.M. Senderova, I.V. Vasil’eva, E.Yu. Komartseva, A.A. Kaplina, V.I. Bakhtina, M.A. Mikhalev, Yu.B. Chernykh, E.N. Parovichnikova

  146-153

  03.03.2023

• Identification of Somatic Mutations in EZH2 Gene and Assessment of Their Prognostic Value in Follicular Lymphoma Grades 1–3А

  Ekaterina Sergeevna Nesterova, N.A. Severina, B.V. Biderman, A.B. Sudarikov, A.M. Kovrigina, T.N. Obukhova, Ya.K. Mangasarova, S.M. Kulikov, E.E. Zvonkov, E.N. Parovichnikova, V.G. Savchenko

  80-87

  01.01.2023

• Prognostic Models in Medicine

  Aleksander Sergeevich Luchinin

  27-36

  01.01.2023

• Chronic Hepatitis С and Oncohematological Diseases

  Tamara Vasilevna Antonova, M.S. Nozhkin, D.A. Lioznov

  46-53

  01.01.2023

• Monitoring of Red Cell Donor Chimerism in Oncohematological Patients After Allogeneic Hematopoietic Stem Cell Transplantation

  Mariya Viktorovna Smolnikova, E.V. Butina, A.V. Iovdii, E.A. Poponina, N.A. Zorina

  96-100

  01.01.2023

• The Prognostic Value of Immunophenotypic Characteristics of Plasma Cells in Newly Diagnosed Multiple Myeloma Patients Treated with First-Generation Proteasome Inhibitor Bortezomib

  Galina Nikolaevna Salogub, E.B. Rusanova, M.V. Gorchakova, E.A. Belyakova

  377-387

  01.10.2022

• Prognostic Value of the Degree of Tumor Tissue Infiltration by CD15-Positive Granulocytes in Nodular Sclerosis Classical Hodgkin’s Lymphoma

  Elena Aleksandrovna Perfilova, D.A. D’yakonov, M.S. Minaev

  253-258

  01.07.2022

• Stratification of Patients with Multiple Myeloma: State-of-the-Art and Prospects

  Anna Yurevna Aksenova, A.S. Zhuk, E.I. Stepchenkova, S.V. Gritsaev

  259-270

  01.07.2022

• Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

  E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey

  271-281

  01.07.2022

• Significance of the Expression of pAKT1 and pSyk Activation Proteins in Diffuse Large B-Cell Lymphoma

  Elena Viktorovna Vaneeva, V.A. Rosin, D.A. Dyakonov, S.V. Samarina, I.V. Paramonov

  140-147

  01.04.2022